Why the study?
Does complete revascularization reduce adverse cardiovascular events in diabetic patients with acute ST elevation myocardial infarction and multi-vessel disease undergoing PPCI?
Does complete revascularization reduce adverse cardiovascular events in diabetic patients with acute ST elevation myocardial infarction and multi-vessel disease undergoing PPCI?
In diabetic patients with STEMI and multivessel disease, complete revascularization during primary PCI significantly reduces adverse cardiovascular events compared to culprit-only PCI.
May support complete revascularization in diabetic STEMI with multivessel disease; leaves open confirmation by randomized trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hamza et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: